CGN Nuclear Technology Development (000881) Fundamentals 2026 — Revenue Analysis | SniperIQ
CGN Nuclear Technology Development (000881) is a CN-listed Industrials company in Industrial - Machinery with a market capitalization of ¥5.8B, trading at ¥6.13 on the SHZ. This SniperIQ fundamentals page covers CGN Nuclear Technology Development's valuation, profitability (net margin -5.0%), revenue (¥5.6B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is CGN Nuclear Technology Development's market cap?
CGN Nuclear Technology Development (000881) has a market capitalization of approximately ¥5.8B, trading at ¥6.13 on the SHZ. Market cap moves with the live share price.
What is CGN Nuclear Technology Development's P/E ratio?
CGN Nuclear Technology Development's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 1.2x. Valuation multiples are best compared with Industrials sector peers rather than read in isolation.
How profitable is CGN Nuclear Technology Development?
CGN Nuclear Technology Development runs a net profit margin of -5.0%, a gross margin of 14.4%, and an operating margin of -5.8%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does CGN Nuclear Technology Development generate?
CGN Nuclear Technology Development reported revenue of ¥5.6B for fiscal year 2025, with net income of -¥287M and earnings per share (EPS) of -0.3. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does CGN Nuclear Technology Development pay a dividend?
CGN Nuclear Technology Development does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is CGN Nuclear Technology Development financially healthy?
CGN Nuclear Technology Development carries a debt-to-equity ratio of 0.52x and a current ratio of 1.63x, with a market beta of 0.42. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is CGN Nuclear Technology Development a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For CGN Nuclear Technology Development (000881) the key facts are: market cap ¥5.8B, revenue ¥5.6B, 52-week range 6-9.69. Weigh valuation, profitability, growth, and balance-sheet strength against Industrials peers and form your own view.
Track CGN Nuclear Technology Development's full fundamentals live
Get CGN Nuclear Technology Development's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.